Literature DB >> 23159237

Intraocular vaccination with an inactivated highly pathogenic avian influenza virus induces protective antibody responses in chickens.

Hirokazu Hikono1, Masaji Mase, Aya Matsuu, Megumi Nakayama, Takehiko Saito.   

Abstract

Because it is expected to induce cross-reactive serum and mucosal antibody responses, mucosal vaccination against highly pathogenic avian influenza (HPAI) is potentially superior to conventional parenteral vaccination. Here, we tested whether intraocular vaccination with an inactivated AI virus induced protective antibody responses in chickens. Chickens were inoculated intraocularly twice with 10(4) hemagglutination units of an inactivated H5N1 HPAI virus. Four weeks after the second vaccination, the chickens were challenged with a lethal dose of the homologous H5N1 HPAI virus. Results showed that most of the vaccinated chickens mounted positive antibody responses. The median serum hemagglutination inhibition titer was 1:80. Addition of CpG oligodeoxynucleotide 2006 or cholera toxin to the vaccine did not enhance serum antibody titers. Cross-reactive anti-hemagglutinin IgG, but not IgA, was detected in oropharyngeal secretions. In accordance with these antibody results, most vaccinated chickens survived a lethal challenge with the H5N1 HPAI virus and did not shed the challenge virus in respiratory or digestive tract secretions. Our results show that intraocular vaccination with an inactivated AI virus induces not only systemic but also mucosal antibody responses and confers protection against HPAI in chickens.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159237     DOI: 10.1016/j.vetimm.2012.10.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  5 in total

1.  Prime-boost vaccination strategy against avian influenza and Newcastle disease viruses reduces shedding of the challenge viruses.

Authors:  Nermeen M Ismail; Ayman H El-Deeb; Mohamed M Emara; Hoda I Tawfik; Nabil Abdel Wanis; Hussein A Hussein
Journal:  Virusdisease       Date:  2018-06-26

2.  Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.

Authors:  Eun-Do Kim; Soo Jung Han; Young-Ho Byun; Sang Chul Yoon; Kyoung Sub Choi; Baik Lin Seong; Kyoung Yul Seo
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

3.  Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.

Authors:  Song Yang; Shumeng Niu; Zhihua Guo; Ye Yuan; Kun Xue; Sinan Liu; Hong Jin
Journal:  Virol J       Date:  2013-09-22       Impact factor: 4.099

4.  Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.

Authors:  Julia Sarkadi; Mate Jankovics; Zoltan Kis; Jozsef Skare; Kinga Fodor; Eva Gonczol; Ildiko Visontai; Zoltan Vajo; Istvan Jankovics
Journal:  Arch Virol       Date:  2013-06-15       Impact factor: 2.574

5.  Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.

Authors:  Tamiru Negash Alkie; Alexander Yitbarek; Khaled Taha-Abdelaziz; Jake Astill; Shayan Sharif
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.